Seminars in Hematology
Volume 45, Issue 3 , Pages 150-159, July 2008

Decision-Making When Data and Inferences Are Not Conclusive: Risk-Benefit and Acceptable Regret Approach

  • Iztok Hozo

      Affiliations

    • Department of Mathematics, Indiana University, Gary, IN.
  • ,
  • Michael J. Schell

      Affiliations

    • Department of Interdisciplinary Oncology, H. Lee Moffitt Cancer Center & Research Institute at the University of South Florida, Tampa, FL.
  • ,
  • Benjamin Djulbegovic

      Affiliations

    • Department of Interdisciplinary Oncology, H. Lee Moffitt Cancer Center & Research Institute at the University of South Florida, Tampa, FL.
    • Corresponding Author InformationAddress correspondence to Benjamin Djulbegovic, MD, PhD, Department of Interdisciplinary Oncology, H. Lee Moffitt Cancer Center & Research Institute at the University of South Florida, 12902 Magnolia Dr, Tampa, FL 33612.

The absolute truth in research is unobtainable, as no evidence or research hypothesis is ever 100% conclusive. Therefore, all data and inferences can in principle be considered as “inconclusive.” Scientific inference and decision-making need to take into account errors, which are unavoidable in the research enterprise. The errors can occur at the level of conclusions that aim to discern the truthfulness of research hypothesis based on the accuracy of research evidence and hypothesis, and decisions, the goal of which is to enable optimal decision-making under present and specific circumstances. To optimize the chance of both correct conclusions and correct decisions, the synthesis of all major statistical approaches to clinical research is needed. The integration of these approaches (frequentist, Bayesian, and decision-analytic) can be accomplished through formal risk:benefit (R:B) analysis. This chapter illustrates the rational choice of a research hypothesis using R:B analysis based on decision-theoretic expected utility theory framework and the concept of “acceptable regret” to calculate the threshold probability of the “truth” above which the benefit of accepting a research hypothesis outweighs its risks.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0037-1963(08)00065-6

doi:10.1053/j.seminhematol.2008.04.006

Seminars in Hematology
Volume 45, Issue 3 , Pages 150-159, July 2008